New Delhi, March 17 -- Fake and falsified obesity drugs could be prompting a public health concern driven by high prices, a lack of insurance and the desire to lose weight, according to a World Report article published in The Lancet journal.

Author Sophie Cousins, an Australian writer and health journalist based in South Asia, writes about how counterfeit Ozempic and Mounjaro are on sale in vacation areas in Mexico and at pharmacies on the border with the US.

Shabbir Safdar, executive director of the Partnership for Safe Medicines, a public health group focused on the security and safety of medicines in the US supply chain, said there is more fraud around weight-loss injectables than he has seen at any other point in his career in track...